Nir Barak, MD

Tharimmune Inc.

Poster(s):

• P1780 - Safety and Tolerability of TH104, Buccal Nalmefene, in Patients With Cholestatic Liver Disease and Pruritus
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET